Department of Paediatric Endocrinology, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK.
Bone. 2011 Feb;48(2):189-96. doi: 10.1016/j.bone.2010.09.034. Epub 2010 Oct 12.
Obese children, particularly those who have fractured, have reduced body size-adjusted total body and regional bone mass. We performed an observational cross-sectional cohort study to determine the relationship between adipokines (leptin and adiponectin), bone-derived cytokines and bone turnover in children which may explain this observation. Participants aged 5-16 years were recruited into obese (BMI SDS 3.3±0.6) and lean (BMI SDS 0.2±1.0) groups and further subdivided into groups by fracture history. Free leptin (leptin/leptin soluble receptor) and adiponectin; RANK-ligand (RANKL), osteoprotegerin (OPG); Dickkopf-1 (DKK1); and the bone turnover markers procollagen type I amino propeptide (P1NP) and carboxy-terminal telopeptide of type I collagen (CTx). Total body and truncal fat mass were measured by DXA.
Free leptin (p>0.0001) and adiponectin (p=0.0002) were higher and lower in obese children respectively. OPG was lower in obese children (p=0.01), being inversely related to free leptin (p=0.009), total body and truncal fat mass (both p=0.01). RANKL was inversely related to free leptin in children with prior fracture (p=0.03). CTx was higher in obese children (p=0.003). Free leptin was positively associated with both CTx (p=0.03) and P1NP (p=0.02). DKK1 was inversely related to adiponectin (p=0.02).
Bone formation relative to resorption was reduced in obese children; this difference was accentuated in those with prior fracture. Adipokines may regulate these changes. Osteoprotegerin may play a fundamental role in the failure of obese children to accrue bone mass appropriately.
肥胖儿童,尤其是骨折儿童,其身体大小调整后的全身和局部骨量减少。我们进行了一项观察性横断面队列研究,以确定脂肪因子(瘦素和脂联素)、骨源性细胞因子和骨转换之间的关系,这些可能可以解释这一观察结果。招募了年龄在 5-16 岁的肥胖(BMI SDS 3.3±0.6)和瘦(BMI SDS 0.2±1.0)儿童,并根据骨折史进一步分为组。测定游离瘦素(瘦素/瘦素可溶性受体)和脂联素;核因子-κB 受体激活配体(RANKL)、骨保护素(OPG);Dickkopf-1(DKK1);以及骨转换标志物Ⅰ型前胶原氨基端肽(P1NP)和Ⅰ型胶原羧基端肽(CTX)。通过 DXA 测量全身和躯干脂肪量。
肥胖儿童的游离瘦素(p>0.0001)和脂联素(p=0.0002)分别升高和降低。肥胖儿童的 OPG 降低(p=0.01),与游离瘦素呈负相关(p=0.009),与全身和躯干脂肪量呈负相关(均 p=0.01)。有骨折史的儿童中,RANKL 与游离瘦素呈负相关(p=0.03)。肥胖儿童的 CTx 升高(p=0.003)。游离瘦素与 CTx(p=0.03)和 P1NP(p=0.02)呈正相关。DKK1 与脂联素呈负相关(p=0.02)。
肥胖儿童的骨形成相对于骨吸收减少;这种差异在有骨折史的儿童中更为明显。脂肪因子可能调节这些变化。OPG 可能在肥胖儿童不能适当增加骨量的过程中发挥重要作用。